Channing Judith Paller MD

Genitourinary Oncology, Hematologic Oncology

Professor of Oncology, Director of Prostate Cancer Clinical Research, Oncology Director John Hopkins Clinical Research Network, Johns Hopkins University School of Medicine

Join to view full profile

5255 Loughboro Road NorthwestBuilding BWashington, DC 20016
Phone+1 202-660-6500
Fax+1 202-660-6501

Dr. Paller is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Paller's full profile Already have an account?

Education & Training

Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2008 - 2011
Johns Hopkins UniversityResidency, Internal Medicine, 2005 - 2008
Harvard Medical SchoolClass of 2005, MD

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

FL State Medical License 2021 - Present
DC State Medical License 2012 - 2027
MD State Medical License 2008 - 2027
VA State Medical License 2021 - 2026
PA State Medical License 2020 - 2022
AL State Medical License 2020 - 2020
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology
Medical OncologyInternal Medicine

Awards, Honors, & Recognition

CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2014, 2016-2017
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2014, 2016-2017
CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017

Clinical Trials

Effects of Two Doses of MPX Capsules on Rising Prostate-specific Antigen Levels in Men Following Initial Therapy for Prostate Cancer
COMPLETED
PHASE1, PHASE2
S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer Start of enrollment: 2013 Mar 08
COMPLETED
PHASE3
Trial of Mistletoe Extract in Patients With Advanced Solid Tumors Start of enrollment: 2017 Mar 01
COMPLETED
PHASE1

Publications & Presentations

PubMed

Recruitment strategies in the PROMISE Registry: Evaluating institutional outreach, direct-to-patient marketing, and community engagement approaches in a decentralized ...
Channing J Paller, Ken Freitas, Natalie Macario, Christina Tran, Kelly Faville
Contemporary Clinical Trials Communications. 2026-10-01
Active Surveillance Use for Favorable-Risk Prostate Cancer in a Veterans Affairs Population.
Grace Lee, John R Bihn, John M Culnan, Jennifer La, Nhan V Do
JAMA. 2026-08-13
Developing a Preliminarily Validated Competency-Based Integrative Oncology Training Questionnaire.
Eran Ben-Arye, Orit Gressel, Elad Schiff, Anat Reiner-Benaim, Maayan Afri Malin
Journal of Pain and Symptom Management. 2026-08-01

Journal Articles

Comparison of Systemic Treatments for Metastatic Castration-Sensitive Prostate Cancer
Channing J Paller, Otis Brawley, JAMA Oncology
Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer
Emmanuel S Antonarakis, Ashley E Ross, Michael A Gorin, Samuel R Denmeade, Channing J Paller, Kenneth J Pienta, Mario A Eisenberger, JAMA Oncology
TGF‐Β Receptor I Inhibitor Enhances Response to Enzalutamide in a Pre‐Clinical Model of Advanced Prostate Cancer
Channing Paller, Cameron A Wade, The Prostate

Lectures

FACTS: Factors affecting combination trial success.
2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018

Press Mentions

Cancer Dietary Supplements: SIO 2025October 28th, 2025
SIO 2025: Common Dietary Supplements and CancerOctober 28th, 2025
Enzalutamide May Have Slight Survival Advantage over Abiraterone for mCRPCAugust 19th, 2024